The Event

Dr. Seenu M. Hariprasad, Shui-Chin Lee Professor of Ophthalmology and Visual Science at The University of Chicago Medicine, discussed the pathophysiology and current management of diabetic retinopathy and diabetic macular edema. He discussed the evolution of several therapies including retina laser photocoagulation, anti-vascular endothelial growth factor agents and corticosteroids. Dr. Hariprasad also presented clinical trial data including the DRCR Network Protocol-T study.  He concluded with a case presentation and a discussion session.

Registration/ 注册: 18:30 – 19:00

Talk and Q&A/ 演讲与问答: 19:00 – 20:30

Light Refreshments/ 简餐: 20:30 – 21:00

Speaker Bio

Since joining the University of Chicago Medicine in 2005, Dr. Hariprasad has gained a reputation as a leading specialist in various vitreoretinal disorders, including AMD, diabetic eye disease, intraocular infection and RVO. He has been recognized for bringing more effective and efficient sutureless microincisional vitrectomy techniques to the medical center.

Dr. Hariprasad’s clinical research has contributed to the understanding and use of new medications to combat a wide variety of vitreoretinal disorders. He has served as principal or sub-investigator in more than 45 national and international clinical trials evaluating various medications, sustained drug-delivery devices and surgical innovations to treat a variety of diseases, such as AMD, diabetic retinopathy and RVO.